These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. How Full-Length FVIII Benefits from Its Heterogeneity - Insights into the Role of the B-Domain. Anzengruber J; Feichtinger M; Bärnthaler P; Haider N; Ilas J; Pruckner N; Benamara K; Scheiflinger F; Reipert BM; Malisauskas M Pharm Res; 2019 Apr; 36(5):77. PubMed ID: 30937539 [TBL] [Abstract][Full Text] [Related]
6. Dimeric Organization of Blood Coagulation Factor VIII bound to Lipid Nanotubes. Dalm D; Galaz-Montoya JG; Miller JL; Grushin K; Villalobos A; Koyfman AY; Schmid MF; Stoilova-McPhie S Sci Rep; 2015 Jun; 5():11212. PubMed ID: 26082135 [TBL] [Abstract][Full Text] [Related]
7. Biochemical, immunological, and in vivo functional characterization of B-domain-deleted factor VIII. Pittman DD; Alderman EM; Tomkinson KN; Wang JH; Giles AR; Kaufman RJ Blood; 1993 Jun; 81(11):2925-35. PubMed ID: 8499631 [TBL] [Abstract][Full Text] [Related]
8. Factor VIII organisation on nanodiscs with different lipid composition. Grushin K; Miller J; Dalm D; Stoilova-McPhie S Thromb Haemost; 2015 Apr; 113(4):741-9. PubMed ID: 25589466 [TBL] [Abstract][Full Text] [Related]
9. 3-Dimensional structure of membrane-bound coagulation factor VIII: modeling of the factor VIII heterodimer within a 3-dimensional density map derived by electron crystallography. Stoilova-McPhie S; Villoutreix BO; Mertens K; Kemball-Cook G; Holzenburg A Blood; 2002 Feb; 99(4):1215-23. PubMed ID: 11830468 [TBL] [Abstract][Full Text] [Related]
10. The structural basis for the functional comparability of factor VIII and the long-acting variant recombinant factor VIII Fc fusion protein. Leksa NC; Chiu PL; Bou-Assaf GM; Quan C; Liu Z; Goodman AB; Chambers MG; Tsutakawa SE; Hammel M; Peters RT; Walz T; Kulman JD J Thromb Haemost; 2017 Jun; 15(6):1167-1179. PubMed ID: 28397397 [TBL] [Abstract][Full Text] [Related]
11. Electron crystallography of human blood coagulation factor VIII bound to phospholipid monolayers. Stoylova SS; Lenting PJ; Kemball-Cook G; Holzenburg A J Biol Chem; 1999 Dec; 274(51):36573-8. PubMed ID: 10593957 [TBL] [Abstract][Full Text] [Related]
12. Development and characterization of recombinant ovine coagulation factor VIII. Zakas PM; Gangadharan B; Almeida-Porada G; Porada CD; Spencer HT; Doering CB PLoS One; 2012; 7(11):e49481. PubMed ID: 23152911 [TBL] [Abstract][Full Text] [Related]
13. Cryo-electron microscopy of coagulation Factor VIII bound to lipid nanotubes. Parmenter CD; Cane MC; Zhang R; Stoilova-McPhie S Biochem Biophys Res Commun; 2008 Feb; 366(2):288-93. PubMed ID: 18039465 [TBL] [Abstract][Full Text] [Related]
14. Role of the B domain in proteolytic inactivation of activated coagulation factor VIII by activated protein C and activated factor X. Khrenov AV; Ananyeva NM; Saenko EL Blood Coagul Fibrinolysis; 2006 Jul; 17(5):379-88. PubMed ID: 16788314 [TBL] [Abstract][Full Text] [Related]
15. Sedimentation Velocity Analytical Ultracentrifugation of Oxidized Recombinant Full-Length Factor VIII. Zakas PM; Healey JF; Smith IW; Lillicrap D; Lollar P Front Immunol; 2020; 11():150. PubMed ID: 32117290 [TBL] [Abstract][Full Text] [Related]
16. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity. Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211 [TBL] [Abstract][Full Text] [Related]
17. Membrane-binding properties of the Factor VIII C2 domain. Novakovic VA; Cullinan DB; Wakabayashi H; Fay PJ; Baleja JD; Gilbert GE Biochem J; 2011 Apr; 435(1):187-96. PubMed ID: 21210768 [TBL] [Abstract][Full Text] [Related]
18. Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding. Liu Z; Lin L; Yuan C; Nicolaes GA; Chen L; Meehan EJ; Furie B; Furie B; Huang M J Biol Chem; 2010 Mar; 285(12):8824-9. PubMed ID: 20089867 [TBL] [Abstract][Full Text] [Related]
19. Haemophilia A: effects of inhibitory antibodies on factor VIII functional interactions and approaches to prevent their action. Saenko EL; Ananyeva NM; Kouiavskaia DV; Khrenov AV; Anderson JA; Shima M; Qian J; Scott D Haemophilia; 2002 Jan; 8(1):1-11. PubMed ID: 11886458 [TBL] [Abstract][Full Text] [Related]
20. Replacing the factor VIII C1 domain with a second C2 domain reduces factor VIII stability and affinity for factor IXa. Wakabayashi H; Fay PJ J Biol Chem; 2013 Oct; 288(43):31289-97. PubMed ID: 24030831 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]